Tri-County Health Care (TCHC) pharmaceutical staff members confirm that TCHC does not have any medications in their pharmacy from the New England Compounding Center (NECC) in Framingham, Mass., the company responsible for the injectable medication linked to the outbreak.
"I am happy to confirm that we do not have, nor have we in the past, received any medications from the NECC," TCHC Pharmacy Manager Aimee Turcotte said. "Patients should have a peace of mind knowing that our facility has not used the potentially contaminated epidural steroid injection involved in the fungal meningitis outbreak."
When medical recalls happen, MedWatch, the FDA's safety information and adverse event reporting program, notifies TCHC immediately.
TCHC encourages everyone who may have received a potentially contaminated medication to seek medical attention, if they have symptoms. Patients have had symptoms generally starting from one to four weeks after their injection.
"Although we haven't administered this medication to our patients at TCHC, it is important to be aware individuals who travel, those who have been referred or those who receive their medical care elsewhere may have received the medication from another facility," Turcotte said.
